MoneyWorks4Me

Sakar Healthcare - Quaterly Results

25 Jul 2026 Evaluate
A decent increase of about 38.37% in the sales to Rs. 729.72 millions was observed for the quarter ended June 2026. The sales figure stood at Rs. 527.36 millions during the year-ago period.The Total revenue for the quarter ended June 2026 of  Rs. 102.85  millions  grew by 120.19% from Rs. 46.71 millions.Operating profit for the quarter ended June 2026 rose to 227.93 millions as compared to 131.00 millions of corresponding quarter ended June 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 729.72 527.36 38.37 729.72 527.36 38.37 2517.36 1775.85 41.76
Other Income 15.44 3.94 291.88 15.44 3.94 291.88 22.87 13.13 74.18
PBIDT 227.93 131.00 73.99 227.93 131.00 73.99 711.76 509.96 39.57
Interest 16.70 21.43 -22.07 16.70 21.43 -22.07 78.56 85.35 -7.96
PBDT 211.23 109.57 92.78 211.23 109.57 92.78 633.20 424.10 49.30
Depreciation 65.42 55.72 17.41 65.42 55.72 17.41 235.64 208.82 12.84
PBT 145.81 53.85 170.77 145.81 53.85 170.77 397.56 215.28 84.67
TAX 42.96 7.14 501.68 42.96 7.14 501.68 92.71 40.25 130.34
Deferred Tax 3.62 7.14 -49.30 3.62 7.14 -49.30 30.41 40.25 -24.45
PAT 102.85 46.71 120.19 102.85 46.71 120.19 304.85 175.03 74.17
Equity 222.50 222.50 0.00 222.50 222.50 0.00 222.50 219.50 1.37
PBIDTM(%) 31.24 24.84 25.74 31.24 24.84 25.74 28.27 28.72 -1.54
Peers
Company Name CMP
Sun Pharma. Inds. 1864.00
Dr. Reddys Labs. 1140.80
Cipla 1380.00
Lupin 2075.00
Zydus Lifesciences 1118.00
View more..